OPTIVE® GEL DROPS have a unique dual-action formula that delivers long-lasting relief from dry eye symptoms, with similar osmoprotectant benefits to OPTIVE FUSION™.1-3
High-viscosity OPTIVE® GEL DROPS are a drop formula with a high concentration of CMC (1%), spreading thinly across the eye to protect against further irritation.4,5
OPTIVE® GEL DROPS can be used in combination with other products from the OPTIVE® Family.3,6
Caking and blurring of vision are drawbacks of highly viscous agents such as ointments. Less viscous agents like OPTIVE® GEL DROPS help minimise these issues and are fully compatible with contact lens use.4
Provides comfort and lubrication
Long retention time
Hydration of the epithelial cells
Protects against extra salty tears
Restores water balance
Longer lasting comfort
Contact lens compatible
OPTIVE® Family compatible
Place one or two drops of OPTIVE® GEL DROPS in the affected eye(s) as needed.
OPTIVE® Lubricant Eye Drops and OPTIVE® Unit Dose Lubricant Eye Drops: Contains carboxymethylcellulose sodium 5 mg/ml and glycerine 9 mg/ml.
OPTIVE PLUS™ Eye Drops and OPTIVE PLUS™ Unit Dose Eye Drops: Contains carboxymethylcellulose sodium 5 mg/ml, glycerine 10 mg/ml, castor oil 2,5 mg/ml, and polysorbate 80 5 mg/ml.
OPTIVE FUSION™ Eye Drops and OPTIVE FUSION™ Unit Dose Eye Drops: Contains sodium hyaluronate 1 mg/ml, carboxymethylcellulose sodium 5 mg/ml, and glycerine 9 mg/ml.
OPTIVE® Gel Drops: Contains carboxymethylcellulose sodium 10 mg/ml and glycerine 9 mg/ml.
For full prescribing information, refer to the Instructions for Use.
Allergan Pharmaceuticals (Pty) Ltd, PO Box 6024, Halfway House, 1685, South Africa (Co. Reg. no. 1984/005576/07)
Telephone: +27 (0) 11 545 6600, Facsimile: +27 (0) 11 315 6008
www.allergan.co.za
© 2018. ®/™ Registered Trademark/Trademark of Allergan, Inc. ZA/0104/2018d
1. Lievens C et al. 30-Day Study Poster T67, Presented at the AAOpt Annual Meeting, Oct 7–10, 2015, New Orleans, LA.
2. Baudouin C et al. Ocul Surf. 2013;11:246–248.
3. Allergan OPTIVE FUSION™ Labelling, 2017.
4. Allergan OPTIVE® GEL DROPS Labelling, 2017.
5. Benchabane A et al. Colloid Polym Sci. 2008;286:1173–1180.
6. Tong L et al. Cornea. 2012;31(Suppl 1):S32–S36.